Psoriasis as a risk factor of pulmonary embolism - case report

Introduction. Deep vein thrombosis and pulmonary embolism, known as venous thromboembolism, constitute a major global burden of disease. Both entities share the same risk factors. Psoriasis is a common, chronic skin disease. It also presents multisystemic inflammation, mainly affecting skin and join...

Full description

Bibliographic Details
Main Authors: Milić Rade, Šarac Sanja, Lazović-Popović Biljana, Dinić Miroslav
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2019-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2019/0042-84501900077M.pdf
_version_ 1811344635240382464
author Milić Rade
Šarac Sanja
Lazović-Popović Biljana
Dinić Miroslav
author_facet Milić Rade
Šarac Sanja
Lazović-Popović Biljana
Dinić Miroslav
author_sort Milić Rade
collection DOAJ
description Introduction. Deep vein thrombosis and pulmonary embolism, known as venous thromboembolism, constitute a major global burden of disease. Both entities share the same risk factors. Psoriasis is a common, chronic skin disease. It also presents multisystemic inflammation, mainly affecting skin and joints, but it is also associated with the significant cardiovascular and metabolic states and comorbidities, on the so-called “psoriatic march”. Case report. We presented a 78-year-old female patient, with psoriasis associated with pulmonary embolism which is accidentally discovered. We did not find any other predisposing factor of this disease (primary or secondary thrombophilia), except hyperhomocysteinemia. The patient was treated with low molecular weight heparin (enoxaparin), followed by the administration of an oral vitamin K antagonist (warfarin sodium) in the weight adjusted regimens. Additionally, we recommended vitamin B complex, including folate. Supposed link between hyperhomocysteinemia and psoriasis was the decreased serum folate level as the result of increased vitamin utilization in the skin because of increased DNA synthesis. Conclusion. The reported case reflects existing literary knowledge about the increased risk of VTE and arterial thromboembolic events in the psoriatic patients. The highest risk appears in the patients with a severe disease and may be a consequence of systemic inflammation and hyperhomocysteinemia.
first_indexed 2024-04-13T19:51:06Z
format Article
id doaj.art-7ac52d7b74f4403ab9ce4f0711c1a072
institution Directory Open Access Journal
issn 0042-8450
2406-0720
language English
last_indexed 2024-04-13T19:51:06Z
publishDate 2019-01-01
publisher Military Health Department, Ministry of Defance, Serbia
record_format Article
series Vojnosanitetski Pregled
spelling doaj.art-7ac52d7b74f4403ab9ce4f0711c1a0722022-12-22T02:32:33ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502406-07202019-01-0176996897210.2298/VSP170717077M0042-84501900077MPsoriasis as a risk factor of pulmonary embolism - case reportMilić Rade0Šarac Sanja1Lazović-Popović Biljana2Dinić Miroslav3Military Medical Academy, Clinic for Pulmonology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, SerbiaMilitary Medical Academy, Clinic for Pulmonology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, SerbiaUniversity Clinical Hospital Center “Zemun”, Belgrade, SerbiaClinic for Dermatology and Venereology, Belgrade, SerbiaIntroduction. Deep vein thrombosis and pulmonary embolism, known as venous thromboembolism, constitute a major global burden of disease. Both entities share the same risk factors. Psoriasis is a common, chronic skin disease. It also presents multisystemic inflammation, mainly affecting skin and joints, but it is also associated with the significant cardiovascular and metabolic states and comorbidities, on the so-called “psoriatic march”. Case report. We presented a 78-year-old female patient, with psoriasis associated with pulmonary embolism which is accidentally discovered. We did not find any other predisposing factor of this disease (primary or secondary thrombophilia), except hyperhomocysteinemia. The patient was treated with low molecular weight heparin (enoxaparin), followed by the administration of an oral vitamin K antagonist (warfarin sodium) in the weight adjusted regimens. Additionally, we recommended vitamin B complex, including folate. Supposed link between hyperhomocysteinemia and psoriasis was the decreased serum folate level as the result of increased vitamin utilization in the skin because of increased DNA synthesis. Conclusion. The reported case reflects existing literary knowledge about the increased risk of VTE and arterial thromboembolic events in the psoriatic patients. The highest risk appears in the patients with a severe disease and may be a consequence of systemic inflammation and hyperhomocysteinemia.http://www.doiserbia.nb.rs/img/doi/0042-8450/2019/0042-84501900077M.pdfvenous thrombosispulmonary embolismpsoriasisrisk factorscomorbidityhomocysteine
spellingShingle Milić Rade
Šarac Sanja
Lazović-Popović Biljana
Dinić Miroslav
Psoriasis as a risk factor of pulmonary embolism - case report
Vojnosanitetski Pregled
venous thrombosis
pulmonary embolism
psoriasis
risk factors
comorbidity
homocysteine
title Psoriasis as a risk factor of pulmonary embolism - case report
title_full Psoriasis as a risk factor of pulmonary embolism - case report
title_fullStr Psoriasis as a risk factor of pulmonary embolism - case report
title_full_unstemmed Psoriasis as a risk factor of pulmonary embolism - case report
title_short Psoriasis as a risk factor of pulmonary embolism - case report
title_sort psoriasis as a risk factor of pulmonary embolism case report
topic venous thrombosis
pulmonary embolism
psoriasis
risk factors
comorbidity
homocysteine
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2019/0042-84501900077M.pdf
work_keys_str_mv AT milicrade psoriasisasariskfactorofpulmonaryembolismcasereport
AT saracsanja psoriasisasariskfactorofpulmonaryembolismcasereport
AT lazovicpopovicbiljana psoriasisasariskfactorofpulmonaryembolismcasereport
AT dinicmiroslav psoriasisasariskfactorofpulmonaryembolismcasereport